We predict Human Health, in Silico.

Our Ready to Use Products


About Us

Mimesis Srl

MIMESIS is an innovative startup and SpinOff of the University of Catania that applies computational models to the pharmaceutical/nutraceutical sector, allowing the simulation of phenomena of a structural-chemical-biological nature.

Mimesis offers the first generation of “In Silico” solutions to the biomedical industry and pharmaceutical companies to reduce time and costs in the research and development process of medicinal products.

Mimesis cares about ethics since the solutions adopted do not require the use of humans, leading to a potential reduction of the number of patients who take part in clinical studies.

The estimated cost required for the approval of a new drug by regulatory agencies (EMA and FDA) varies between 2 and 3 billion dollars and it takes at least 10 years before the drug arrives on the market.

Mimesis at CMISF 2023

We are delighted to announce that our team member, Marzio Pennisi, recently graced the stage as a... Read More "Mimesis at CMISF 2023"

Mimesis on “La Sicilia”

We are thrilled to share a momentous occasion for our team as the esteemed local newspaper, "La... Read More "Mimesis on “La Sicilia”"

Avicenna Days: October 10/11/12 2023

We are elated to announce that our esteemed founder, Prof. Francesco Pappalardo, took center stage as a... Read More "Avicenna Days: October 10/11/12 2023"